• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质组学和单细胞图谱揭示了乙肝病毒感染的肝内胆管癌的新致病机制。

Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma.

作者信息

Shen Yifei, Xu Shuaishuai, Ye Chanqi, Li Qiong, Chen Ruyin, Wu Wei, Jiang Qi, Jia Yunlu, Zhang Xiaochen, Fan Longjiang, Fu Wenguang, Jiang Ming, Chen Jinzhang, Timko Michael P, Zhao Peng, Ruan Jian

机构信息

Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang Province, People's Republic of China.

Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province, Hangzhou 310000, Zhejiang Province, People's Republic of China.

出版信息

iScience. 2023 Jan 18;26(2):106003. doi: 10.1016/j.isci.2023.106003. eCollection 2023 Feb 17.

DOI:10.1016/j.isci.2023.106003
PMID:36852159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9958296/
Abstract

Despite the epidemiological association between intrahepatic cholangiocarcinoma (ICC) and hepatitis B virus (HBV) infection, little is known about the relevant oncogenic effects. A cohort of 32 HBV-infected ICC and 89 non-HBV-ICC patients were characterized using whole-exome sequencing, proteomic analysis, and single-cell RNA sequencing. Proteomic analysis revealed decreased cell-cell junction levels in HBV-ICC patients. The cell-cell junction level had an inverse relationship with the epithelial-mesenchymal transition (EMT) program in ICC patients. Analysis of the immune landscape found that more CD8 T cells and Th2 cells were present in HBV-ICC patients. Single-cell analysis indicated that transforming growth factor beta signaling-related EMT program changes increased in tumor cells of HBV-ICC patients. Moreover, ICAM1 tumor-associated macrophages are correlated with a poor prognosis and contributed to the EMT in HBV-ICC patients. Our findings provide new insights into the behavior of HBV-infected ICC driven by various pathogenic mechanisms involving decreased cell junction levels and increased progression of the EMT program.

摘要

尽管肝内胆管癌(ICC)与乙型肝炎病毒(HBV)感染之间存在流行病学关联,但对相关致癌作用知之甚少。使用全外显子测序、蛋白质组分析和单细胞RNA测序对32例HBV感染的ICC患者和89例非HBV-ICC患者进行了特征分析。蛋白质组分析显示,HBV-ICC患者的细胞间连接水平降低。细胞间连接水平与ICC患者的上皮-间质转化(EMT)程序呈负相关。免疫图谱分析发现,HBV-ICC患者中存在更多的CD8 T细胞和Th2细胞。单细胞分析表明,HBV-ICC患者肿瘤细胞中与转化生长因子β信号相关的EMT程序变化增加。此外,ICAM1肿瘤相关巨噬细胞与预后不良相关,并促进了HBV-ICC患者的EMT。我们的研究结果为受多种致病机制驱动的HBV感染ICC的行为提供了新的见解,这些机制包括细胞连接水平降低和EMT程序进展增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/4f2a35768be0/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/849aaaf45eaf/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/fbed8663653b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/7c9fef254554/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/457b06a20dff/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/8f2341d3f411/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/09d92922dcce/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/987bf9b5bee1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/4f2a35768be0/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/849aaaf45eaf/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/fbed8663653b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/7c9fef254554/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/457b06a20dff/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/8f2341d3f411/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/09d92922dcce/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/987bf9b5bee1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af73/9958296/4f2a35768be0/gr7.jpg

相似文献

1
Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma.蛋白质组学和单细胞图谱揭示了乙肝病毒感染的肝内胆管癌的新致病机制。
iScience. 2023 Jan 18;26(2):106003. doi: 10.1016/j.isci.2023.106003. eCollection 2023 Feb 17.
2
Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma.病毒整合分析揭示了乙型肝炎病毒感染的肝内胆管癌和肝细胞癌-胆管细胞癌合并癌中致癌机制的新见解。
Hepatol Int. 2022 Dec;16(6):1339-1352. doi: 10.1007/s12072-022-10419-3. Epub 2022 Sep 20.
3
Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.乙型肝炎病毒相关肝内胆管癌:一种具有肝细胞癌和肝内胆管癌独特特征的恶性肿瘤。
Oncotarget. 2017 Mar 7;8(10):17292-17300. doi: 10.18632/oncotarget.14079.
4
Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.乙型肝炎病毒感染:肝内胆管细胞癌切除术后的有利预后因素。
World J Gastroenterol. 2011 Mar 14;17(10):1292-303. doi: 10.3748/wjg.v17.i10.1292.
5
Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors.不同危险因素的肝内胆管癌患者中 PD-L1/PD1 的不同表达谱及其临床意义。
Theranostics. 2019 Jul 9;9(16):4678-4687. doi: 10.7150/thno.36276. eCollection 2019.
6
Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.爱泼斯坦-巴尔病毒相关肝内胆管癌的临床病理特征、肿瘤免疫微环境及基因组格局
J Hepatol. 2021 Apr;74(4):838-849. doi: 10.1016/j.jhep.2020.10.037. Epub 2020 Nov 17.
7
Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population.中国隐源性肝内胆管癌患者群体中的隐匿性乙型肝炎病毒感染
J Clin Gastroenterol. 2014 Nov-Dec;48(10):878-82. doi: 10.1097/MCG.0000000000000058.
8
HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.血清甲胎蛋白水平升高的乙肝病毒相关肝内胆管癌:一例报告并文献复习
BMC Infect Dis. 2016 Jun 14;16:295. doi: 10.1186/s12879-016-1643-7.
9
Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours.乙型肝炎病毒感染患者肝内胆管癌的特征:切除肿瘤的临床病理研究。
J Viral Hepat. 2013 May;20(5):306-10. doi: 10.1111/jvh.12005. Epub 2012 Sep 13.
10
Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma.肝内胆管癌中乙型肝炎病毒DNA整合模式的特征分析
Hepatol Res. 2021 Jan;51(1):102-115. doi: 10.1111/hepr.13580. Epub 2020 Nov 6.

引用本文的文献

1
Polarization of Tumor Cells and Tumor-Associated Macrophages: Molecular Mechanisms and Therapeutic Targets.肿瘤细胞与肿瘤相关巨噬细胞的极化:分子机制与治疗靶点
MedComm (2020). 2025 Sep 1;6(9):e70372. doi: 10.1002/mco2.70372. eCollection 2025 Sep.
2
Impact of Antiviral Treatment on Survival in HBV-Related Intrahepatic Cholangiocarcinoma Patients After Hepatectomy: A 14-Year Retrospective Follow-Up Study Based on the Propensity Score Matching Method.抗病毒治疗对乙肝相关肝内胆管癌患者肝切除术后生存的影响:一项基于倾向评分匹配法的14年回顾性随访研究
Ther Clin Risk Manag. 2025 Jun 11;21:869-884. doi: 10.2147/TCRM.S520629. eCollection 2025.
3

本文引用的文献

1
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.clusterProfiler 4.0:用于解释组学数据的通用富集工具。
Innovation (Camb). 2021 Jul 1;2(3):100141. doi: 10.1016/j.xinn.2021.100141. eCollection 2021 Aug 28.
2
Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas.乙型肝炎病毒感染的肝内胆管癌中病毒整合和基因组畸变的综合特征分析
Hepatology. 2022 Apr;75(4):997-1011. doi: 10.1002/hep.32135. Epub 2021 Dec 5.
3
Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma.
PPIH is a novel diagnostic biomarker associated with immune infiltration in cholangiocarcinoma.
PPIH是一种与胆管癌免疫浸润相关的新型诊断生物标志物。
BMC Cancer. 2025 Feb 7;25(1):218. doi: 10.1186/s12885-025-13607-0.
4
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints.胆管癌中的浸润性T淋巴细胞与肿瘤微环境:免疫异质性、细胞间通讯、免疫检查点
Front Immunol. 2025 Jan 8;15:1482291. doi: 10.3389/fimmu.2024.1482291. eCollection 2024.
5
Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic.下一代抗病毒药物与肥胖流行时代的肝癌预防
Hepatology. 2025 Jan 14. doi: 10.1097/HEP.0000000000001227.
6
Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches.通过组学和多组学方法揭示肝内胆管癌的异质性
Cancers (Basel). 2024 Aug 20;16(16):2889. doi: 10.3390/cancers16162889.
7
Single-cell Technologies Provide Novel Insights into Liver Physiology and Pathology.单细胞技术为肝脏生理学和病理学提供了新的见解。
J Clin Transl Hepatol. 2024 Jan 28;12(1):79-90. doi: 10.14218/JCTH.2023.00224. Epub 2023 Sep 1.
肝内胆管癌结局的遗传决定因素。
Hepatology. 2021 Sep;74(3):1429-1444. doi: 10.1002/hep.31829.
4
Multi-organ proteomic landscape of COVID-19 autopsies.COVID-19 尸检的多器官蛋白质组学图谱。
Cell. 2021 Feb 4;184(3):775-791.e14. doi: 10.1016/j.cell.2021.01.004. Epub 2021 Jan 9.
5
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis.Fat1 缺失促进混合 EMT 状态、肿瘤干性和转移。
Nature. 2021 Jan;589(7842):448-455. doi: 10.1038/s41586-020-03046-1. Epub 2020 Dec 16.
6
LAIR-1 overexpression inhibits epithelial-mesenchymal transition in osteosarcoma via GLUT1-related energy metabolism.LAIR-1 过表达通过 GLUT1 相关的能量代谢抑制骨肉瘤中的上皮-间充质转化。
World J Surg Oncol. 2020 Jun 20;18(1):136. doi: 10.1186/s12957-020-01896-7.
7
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.COVID-19 患者血清的蛋白质组学和代谢组学特征。
Cell. 2020 Jul 9;182(1):59-72.e15. doi: 10.1016/j.cell.2020.05.032. Epub 2020 May 28.
8
Advancing Cancer Research and Medicine with Single-Cell Genomics.单细胞基因组学推动癌症研究和医学发展。
Cancer Cell. 2020 Apr 13;37(4):456-470. doi: 10.1016/j.ccell.2020.03.008.
9
TMTpro reagents: a set of isobaric labeling mass tags enables simultaneous proteome-wide measurements across 16 samples.TMTpro 试剂:一套等压标记质量标签可实现 16 个样本的全蛋白质组范围的同时测量。
Nat Methods. 2020 Apr;17(4):399-404. doi: 10.1038/s41592-020-0781-4. Epub 2020 Mar 16.
10
Accelerated Lysis and Proteolytic Digestion of Biopsy-Level Fresh-Frozen and FFPE Tissue Samples Using Pressure Cycling Technology.利用压力循环技术加速活检级新鲜冷冻和 FFPE 组织样本的溶解和蛋白水解消化。
J Proteome Res. 2020 May 1;19(5):1982-1990. doi: 10.1021/acs.jproteome.9b00790. Epub 2020 Mar 30.